Mohamed Kharfan-Dabaja: Management of R/R mantle cell lymphoma by Amer Beitinjaneh at the IACH2024

Mohamed Kharfan-Dabaja shared a post on X:

“Outstanding presentation on management of relapsed/refractory mantle cell lymphoma by Amer Beitinjaneh at the IACH2024, COLYM in Paris.”

Amer Beitinjaneh shared this post, adding:

“Thank you, Mohamed Kharfan-Dabaja, Mohamad Mohty for the invitation to be on the faculty at the IACH meeting in Paris to share our update on the management of R/R mantle cell lymphoma.Truly impressed by the meeting agenda and organization. Looking forward to next year’s meeting.”

Sources: Mohamed Kharfan-Dabaja/X and Amer Beitinjaneh/X

Mohamed Kharfan-Dabaja, M.D., M.B.A. is the Vice Chair and a hematologist-oncologist in the Blood and Marrow Transplant and Cellular Therapy (CAR-T) programs at Mayo Clinic in Jacksonville, Florida. His primary research interest focuses on developing conditioning regimens for allogeneic stem cell transplants, particularly using reduced-intensity conditioning.

Amer Beitinjaneh is an Associate Professor of Medicine at the University of Miami Sylvester Comprehensive Cancer Center. He is a Clinical Investigator and leader of the Bone Marrow Transplantation and Cellular Therapy program. His clinical research focuses on the long-term effects of stem cell transplantation, alternative donor transplantation, targeted therapy, and immune and cellular therapies for aggressive lymphomas.